Total planned funding: $206,721,135
Clear active filters
Implementing Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| South Africa | $36,131,974 |
| Nigeria | $27,778,140 |
| Uganda | $24,548,999 |
| Zimbabwe | $22,228,191 |
| Zambia | $16,175,012 |
| Ethiopia | $13,763,824 |
| Tanzania | $10,962,123 |
| Côte d'Ivoire | $10,077,001 |
| Kenya | $9,457,688 |
| Dominican Republic | $8,549,867 |
| Mozambique | $7,782,545 |
| Malawi | $5,050,000 |
| Lesotho | $3,612,811 |
| Ghana | $2,173,000 |
| Haiti | $1,482,716 |
| Caribbean Region | $1,350,000 |
| Indonesia | $1,300,000 |
| Guyana | $900,000 |
| Vietnam | $875,406 |
| Cameroon | $757,303 |
| Namibia | $633,759 |
| Botswana | $550,000 |
| Cambodia | $322,776 |
| Ukraine | $200,000 |
| Eswatini | $50,000 |
| Asia Regional Program | $8,000 |
Organizational Types
| Implementing Agency | $206,721,135 |
Program Areas
| Treatment | $74,259,760 |
| Care | $58,782,880 |
| Prevention | $43,140,181 |
| Governance and Systems | $21,066,357 |
| Testing | $9,471,959 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $68,226,981 |
| HBHC: Care: Adult Care and Support | $22,007,942 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,071,640 |
| HVTB: Care: TB/HIV | $16,706,706 |
| HKID: Care: Orphans and Vulnerable Children | $16,653,609 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $13,716,440 |
| HVCT: Testing: HIV Testing and Counseling | $9,471,959 |
| HLAB: Laboratory Infrastructure | $8,959,681 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $7,956,954 |
| HVSI: Strategic Information | $6,595,674 |
| PDTX: Treatment: Pediatric Treatment | $6,032,779 |
| OHSS: Health Systems Strengthening | $5,511,002 |
| PDCS: Care: Pediatric Care and Support | $3,414,623 |
| HMBL: Biomedical Prevention: Blood Safety | $1,906,241 |
| HMIN: Biomedical Prevention: Injection Safety | $810,912 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $621,994 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $56,000 |
| HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
University of the Witwatersrand:
$19,210,870
View countries